During the past decade, Landesnervenklinik Wagner Jauregg conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Landesnervenklinik Wagner Jauregg" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "Isarna Therapeutics GmbH" with 1 trials sponsored, "Prof. Dr. Wolfgang Wick" with 1 trials sponsored, "Sygnis Bioscience GmbH & Co KG" with 1 trials sponsored and "ThromboGenics" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Landesnervenklinik Wagner Jauregg" #1 collaborator was "Essex Pharma GmbH" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Landesnervenklinik Wagner Jauregg" are "Glioblastoma" (2 trials), "Acute Ischemic Stroke" (1 trials), "Anaplastic Astrocytoma" (1 trials), "Central Nervous System Tumors" (1 trials) and "Recurrent High Grade Meningioma" (1 trials). Many other conditions were trialed in "Landesnervenklinik Wagner Jauregg" in a lesser frequency.

Most popular intervention types in "Landesnervenklinik Wagner Jauregg" are "Drug" (6 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AP 12009 10 µM" (1 trials), "AP 12009 80 µM" (1 trials), "Bevacizumab" (1 trials), "Drug delivery system for administration of AP 12009" (1 trials) and "Filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Landesnervenklinik Wagner Jauregg" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Landesnervenklinik Wagner Jauregg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Landesnervenklinik Wagner Jauregg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Landesnervenklinik Wagner Jauregg, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".